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Abstract
Background: In health services research, composite scores to measure changes in health-seeking behaviour and
uptake of services do not exist. We describe the rationale and analytical considerations for a composite primary
outcome for primary care research. We simulate its use in a large hypothetical population and use it to calculate
sample sizes. We apply it within the context of a proposed cluster randomised controlled trial (RCT) of a Community
Health Worker (CHW) intervention.
Methods: We define the outcome as the proportion of the services (immunizations, screening tests, stop-smoking
clinics) received by household members, of those that they were eligible to receive. First, we simulated a population
household structure (by age and sex), based on household composition data from the 2011 England and Wales
census. The ratio of eligible to received services was calculated for each simulated household based on published
eligibility criteria and service uptake rates, and was used to calculate sample size scenarios for a cluster RCT of a
CHW intervention. We assume varying intervention percentage effects and varying levels of clustering.
Results: Assuming no disease risk factor clustering at the household level, 11.7% of households in the hypothetical
population of 20,000 households were eligible for no services, 26.4% for 1, 20.7% for 2, 15.3% for 3 and 25.8% for 4 or
more. To demonstrate a small CHW intervention percentage effect (10% improvement in uptake of services out of
those who would not otherwise have taken them up, and additionally assuming intra-class correlation of 0.01 between
households served by different CHWs), around 4,000 households would be needed in each of the intervention and
control arms. This equates to 40 CHWs (each servicing 100 households) needed in the intervention arm. If the CHWs
were more effective (20%), then only 170 households would be needed in each of the intervention and control arms.
Conclusions: This is a useful first step towards a process-centred composite score of practical value in complex
community-based interventions. Firstly, it is likely to result in increased statistical power compared with multiple
outcomes. Second, it avoids over-emphasis of any single outcome from a complex intervention.
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Background
There are many challenges in designing studies of com-
plex interventions [1], one of which is to decide upon
appropriate outcome measures. When undertaking a
randomised trial, and other evaluation studies, it is desir-
able to find a single primary outcome measure so that
statistically robust conclusions about the success of the
intervention can be made. Meta-analysis then becomes
possible in a review of similar complex intervention
effects [2]. When the intervention has a wide variety of
potential outcomes it is much harder to identify the sin-
gle primary outcome of choice. Selecting one outcome
over several possible alternatives may distort the overall
purpose of the trial [3]. An alternative may be to collect
many different measures to assess the effectiveness of
the intervention, yet this may require statistical adjust-
ments such as the Bonferroni correction [4].
In clinical trials, composite outcome scores have be-
come widely used where multiple possible outcomes may
arise from an intervention [5-7]. ‘All-cause mortality’ or
‘time to treatment failure’ are composed of multiple
individual outcomes and, when well-combined, defined
and reported [8], have the benefits of increasing statistical
precision of the trial, without resorting to an arbitrary
selection of one primary outcome over another [9].
However, in health services research or where complex
interventions are proposed, it may be more useful to
measure changes in the delivery of care. Measurement
of changes to hard clinical outcomes may be beyond the
scope of a trial. In such instances, there may be many
potential process outcomes of interest. There is little if
any guidance, however, on how to develop a composite
process indicator for a complex intervention. Guidance
on process evaluations of complex interventions, such as
the recent comprehensive guidance from the Medical
Research Council [10], focus on mixed methods research
to capture the quantitative and qualitative aspects of a
change process. It would, however, be useful to be able
to develop a composite score of process outcomes, such
as service utilisation, particularly in trial situations.
The use of Community Health Workers (CHWs) is
one such example of an intervention that can have many
potential process outcomes of interest. CHWs are de-
fined as members of the local community, who are en-
gaged in local health promotion activities, yet who have
less training than other health professionals such as
nurses. The World Health Organisation (WHO) pro-
motes their use globally and particularly in developing
countries, in response to a lack of fully trained medical
professionals [11].
We discuss here how the impact of CHWs (and other
interventions with a similar intention) might be evalu-
ated using a novel composite process outcome indicator.
In our example, we assume that CHWs would visit all
households (in their allocated geographical area and reg-
istered with the GP to whom the CHW reports) on a
monthly basis. Their remit would be to offer a compre-
hensive and wide range of health support and advice, to
each member of the household at least once per month
irrespective of expressed need or demand - consistent
with a similar model that is working successfully on a
large scale in Brazil [12-20]. For such an intervention,
we would expect there to be a wide number of potential
outcomes ranging from improving uptake of screening
and immunisation services to promoting healthy behav-
iours. One goal would be to measure the potential of the
proposed CHW to increase the uptake of immunisation,
screening services and other services that are currently
available on the National Health Service (NHS). In the
context of a trial, it would be necessary to identify a suit-
able primary outcome measure. However, as the CHWs
deliver advice and support across a wide range of health
domains and age groups it is impossible to identify the
single primary outcome measure of choice without
distorting the purpose of an eventual trial. Furthermore,
an intervention such as this, focusing particularly on in-
creasing the uptake of preventive interventions, is unlikely
to have an effect on hard clinical outcomes within the dur-
ation of a feasibility study. Process measures such as up-
take of services are an interesting alternative because they
help explain how clinical changes come about and, in the
case of this proposed community-based service, are closer
to the level of the intervention. However, there may be
several process outcomes of equal interest and so one op-
tion may be to construct a composite outcome score to
capture as much of the total effect of the CHW as possible.
We have been exploring the possibility of embedding
such a service into local GP practices in deprived com-
munities in North Wales [21]. It is in this context that
we describe the rationale and analytical considerations
for this process (rather than clinical) composite outcome
score. We simulate its use in a large hypothetical popu-
lation, and use it to calculate sample sizes for a suitably
powered cluster randomised controlled trial (RCT) in
this context. Our proposed composite primary outcome,
which we call the Composite Referral Completion Indi-
cator (CRCI), for evaluation of the CHW intervention
reflects uptake rates of a number of screening tests and
immunisations and attendance at stop-smoking clinics.
This outcome is defined at the household level, which
corresponds to the level at which the CHW intervention
is delivered. It evaluates the success with which the
CHW is able to improve the uptake of services by
household members that are eligible for those services.
This article may serve as a useful example of how a
process composite score may be designed around a
complex intervention, and may help others to find ap-
propriate outcomes for their own purposes.
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Methods
We define the CRCI as the proportion of the services re-
ceived by household members, of those that they were
eligible to receive. It is calculated as the number of sched-
uled (or later than scheduled) screening tests and/or
scheduled immunisations received by household members
plus number of people who attend stop-smoking clinics
divided by the number of screening tests and/or immuni-
sations and/or stop-smoking clinics that household mem-
bers are eligible for during the study period. For instance,
a household might consist of one single woman who,
based on her age, is eligible only for one service - the cer-
vical smear test. If she receives this test, within the desig-
nated time period of the study, then the CRCI would be
calculated to be one (one divided by one, that is full up-
take of the service). If she did not take up the screening
then it would be calculated to be zero (zero divided by
one). In an alternative household where there is a child
who is eligible only for the influenza immunisation, a
mother who is eligible for both breast cancer and cervical
screening, and a father who is not eligible for anything,
the denominator for the CRCI would be three. If only one
of these services is taken up during the study period then
the CRCI would be calculated to be 1/3.
We define a household as one or more people living in
one postal address. We define a household member as
anyone ordinarily resident in the household, including
babies born to the household during the study. We de-
fine a household member to be eligible for a service if
they meet the standard criteria for them to be eligible
for a service provided on the NHS. These criteria are
usually based on age and sex, established for each indi-
vidual screening or immunisation programme during the
study period. Equally, we define uptake of a service if
this has occurred anytime during the study period and
up to 3 months after the study period. It is possible to
extend the CRCI definition to include household mem-
bers who move in and out, by including household
members’ service needs into the denominator, scaled ac-
cording to the proportion of the study period that they
live in the household, and by including their met service
needs into the numerator. The simulation exercise does
not include such complexities, since allowance for them
is unlikely to appreciably affect the power. Table 1 shows
the immunisations, screening procedures and other ser-
vices currently offered on the NHS and the uptake rates
currently achieved in North Wales, where our feasibility
work took place. We list the services according to their
age and sex criteria. It further shows the proportion of
households who will have a member in each age/sex
group. This sets out the potential for improvement,
which will be measured by the CRCI, and so is a starting
point for assessing realistic estimates to put into sample
size calculations.
The CRCI outcome measure is calculated for each
household and can be analysed as a proportion. In order
to find the characteristics (mean and standard deviation)
of the CRCI for use in sample size calculations, we simu-
lated the characteristics of the CRCI against a hypothe-
sised population. In order to do this, we firstly find the
age/sex distribution within households, in order to apply
the uptake of service information provided in Table 1.
The age/sex distribution of households is not available
from routine data without complex triangulation be-
tween multiple data sources in primary and social care,
so we have simulated a population household structure
(by age and sex), based initially on household compos-
ition data from census data from England and Wales.
We simulated the distribution of households by number
of occupants and by the age and sex mix within each
household. This was based on the distribution of house-
hold types [22] and number of occupants by household
type [23] in England and Wales as reported by the Office
for National Statistics (ONS), which divides household
types into those which are single occupancy, married cou-
ples, same-sex civil partnerships, cohabiting couples and
lone parents, student households and other households.
Cohabiting couples were distributed amongst married cou-
ples and same-sex civil partnerships [24]. Some of these
categories are further divided by ONS into those with
dependent children (one child, two or more children), only
non-dependent children and no children. Some categories
(for example, single occupancy) are also divided by ONS
into those over and below 65 years (all above this age for
multiple occupancy household). Ages of parents of chil-
dren were derived from ages of parents on giving birth
[25]. Relative ages of siblings were made to fit in with ONS
data on distribution of ages of youngest child, by number
of dependent children [26]. Sex distributions of lone par-
ents and of same-sex civil partnerships were derived from
published ONS data [27]. Age and sex distribution of the
simulated population was made to match with the age and
sex distribution of England and Wales [28]. The above
process resulted in a distribution of households of varying
sizes from single occupancy to containing eight occupants
(the maximum size that we considered), by age band and
sex. A random sample of 20,000 households was then se-
lected, sampled according to frequency of different house-
hold constitutions by age and sex.
We then applied the characteristics of smoking, dia-
betes and pregnancy by age and sex group, since there
are defined interventions for each of these groups. A
simple random process was used to determine who in
our random sample of individuals within households
has each characteristic. Eligibility to different screen-
ing tests, immunisations or services was allocated
based on the current criteria for each separate service
[29-37].
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Table 1 Eligibility for screeninga and immunisationa procedures and smoking cessation clinic on the National Health
Service (NHS), with uptake rates currently achieved in North Wales
Household
member type
Populationb
distribution
by age/sex
group
Proportionc
of HHs with
a member of
this type
Service 1 Uptake %
(service 1)
Service 2 Uptake %
(service 2)
Service 3 Uptake %
(service 3)
New service
Baby 0 to
11 months
1.2% 2.8% DPT/Hib 96.9 Pneumococcal 96.6 Meningococcal 96.6 Rotavirus
Infant 12 to23
months
1.3% 3.0% Pneumococcal 94.3 Hib/MenC 94.5 MMR 93.5
Infant 2 years 1.3% 3.0% Influenza
Infant 3 years 1.3% 3.0% DPT/polio 92.3 MMR 93.5 Influenza
Child 4 to
15 years
13.5% 23.3% Influenza
(includes girls
13/14 years)
(1.1%) (2.8%) HPV 83.4
Youth 16 to
19 years
4.7% 8.6% Chlamydiab
Female 20 to
25 years
3.8% 7.9% Cervicalb 76.5 Chlamydiab
Female 26 to
49 years
17.2% 39.9% Cervicalb 76.5
Female 50 to
59 years
6.1% 13.6% Cervicalb 76.5 Breastb 73.3
Female 60 to
64 years
2.9% 6.7% Cervicalb 76.5 Breastb 73.3 Bowelb 54.0
Female 65 to
70 years
2.8% 6.6% Breastb 73.3 Bowelb 54.0 Influenza 68.2 Varicella
Female 71 to
74 years
1.7% 3.9% Influenza 68.2
Female 75 years
plus
4.6% 10.5% Influenza 68.2
Male 20 to
25 years
3.6% 7.1% Chlamydiab
Male 26 to
59 years
22.6% 49.9%
Male 60 to
64 years
2.8% 6.2% Bowelb 54.0
Male 65 to
70 years
2.9% 6.7% Bowelb 54.0 Influenza 68.2
Male 71 to
74 years
1.4% 3.2% Influenza 68.2 Varicella
Male 75 years
plus
3.1% 7.2% Influenza 68.2
Pregnant
women
1.3% 3.0% Influenza 43.1
Diabetics over
12 years
2.8% 6.5% Retinalb 81.0
At high risk (for
example, CVD)
4.5% 10.3% Influenza 52.0
Smokers of
any age
19.0% 38.2% Smoking
cessation
9.0
aServices included in the Composite Referral Completion Indicator (CRCI), according to age and sex, based on England and Wales uptake rates currently achieved.
bPopulation distribution within each age and sex band, based on England and Wales population structurea.
cProportion of households that have one or more members within each specified age/sex band, based on England and Wales population structurea.
Abbreviations; CVD cardiovascular disease, HH households.
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The rates of diabetes, smoking, and of being in an ‘at
risk’ category for the seasonal influenza immunisation,
were based on reported rates by age and sex [38]. Smok-
ing rates are taken from Cancer Research UK statistics
[39]. Pregnancy rates were assumed to be constant
amongst married couples, as well as allowing for some
pregnancies amongst dependent teenagers; overall rates
are set to equal birth rates in England and Wales [25]
and allowing for 12 months of pregnancies to be in-
cluded at any specified gestational age. These character-
istics were allocated to individuals within households by
random Bernoulli distributions, according to eligibility
and prevalence in each age and sex group - with
diabetics always classified as ‘at risk’ for the seasonal
influenza immunisation. The uptake rates of screening
tests and immunisations were based on reported uptake
rates for Wales, or North Wales, as available [40].
For the purposes of this simulation, we took the study
to have 1 year of follow-up and based the eligibility for
interventions within each age/sex group on this 1-year
period. For immunisations, those within the appropriate
age ranges are taken to be eligible for the intervention.
For adult screening programmes, some services are avail-
able only every 2 or 3 years and allowance is made for the
provision to make up for missed screening tests. Assum-
ing uptake is evenly distributed during the period that the
service is available, the proportion of the age/sex group
eligible during any single year is a third (for 3-yearly
screening, or a half for 2-yearly), with an allowance for the
proportion who are just coming into the age range (who
are all eligible), plus a proportion of the remainder who
did not previously attend (1 − uptake rate).
Uptake rates of the different screening tests and
immunisations were then used to simulate how many of
the eligible people had taken up these opportunities
within households, based on random sampling from the
binomial distribution with the reported uptake rates as
the population proportion. This gives the anticipated up-
take rates in the control arm of the CHW intervention
study. For the treatment arm (with the CHW interven-
tion), we simulated that 10%, 20% and 30% of those that
had not taken up the service take them up because of the
CHW home visit (that is the initial reported uptake rate,
proportion r, is increased to uptake rate r + 0.1 × (1 − r)
for a 10% intervention percentage effect). Again random
sampling from the binomial distribution with these new
uptake rates is applied to find the distribution of individ-
uals within households who have and have not taken up
the interventions (out of any eligible).
The CRCI ratio was calculated for each household. The
denominator is the total number of services that the speci-
fied household is eligible for, summed across all service
types (listed in Table 1), with duplicate counting of any
that more than one person is eligible for. The numerator
is the total number of these services taken up during the
study period, and so must be between zero (for house-
holds who do not comply with anything) and the denom-
inator (for fully compliant households). There are some
households who are not eligible for any services. The
CRCI is undefined for them (with numerator and denom-
inator of zero).
The mean and standard deviation of the CRCIs (mea-
sured at household level) are computed in our random
sample of 20,000 households, for the control arm (based
on current uptake rates) and for the CHW intervention
arms (with various levels of effectiveness). These are used
to calculate sample sizes required for an individually RCT
of the CHW intervention, using standard formulae for
comparison of two means [4] adjusted for the design effect
and intra-class correlation coefficient (ICC) [4].
Various sensitivity analyses were then undertaken as
follows. We examined the effect of removing some of
the screening/immunisations and we estimated the effect
of the disease risk factors (smoking, diabetes and ‘at risk’
re influenza immunisation) being very similar within
households, rather than being randomly distributed
amongst households. We also explored the effect of
assuming that 50% of households were generally adher-
ent and 50% generally non-adherent to the intervention.
The uptake rate in the compliant households was taken
to be over 99% (more precisely uptake rate, r, was
increased to r + 0.99 × (1 − r)), and in less compliant
households, the uptake rate was reduced by the same
amount (to r − 0.99 × (1 − r), with a modification for
rates < 50%). The effect of undertaking this intervention
in a deprived area was also assessed by using the distri-
bution of households with the highest proportion of lone
parent households (Barking and Dagenham in Outer
London). This study did not require ethical approval.
Results
Table 1 shows the different screening tests and immuni-
sations that people are eligible for on the NHS, for inclu-
sion in CRCI outcome, according to age and sex. Most
age/sex groups are eligible for at least one intervention,
and hence the CRCI will be defined on any households
containing them. The main exception is middle-aged
men, who are only eligible for an intervention if they
smoke, have diabetes or are otherwise considered high-
risk and in need of the seasonal flu vaccination. Hence
the CRCI is not always defined on a household that con-
tains only one or a few middle-aged men. Some age/sex
groups are eligible for more than one service, such as in-
fants and middle-aged women scheduled for cancer
screening tests. The table also shows the proportions of
the simulated population (based on the England and
Wales population structure) that fall within each age/sex
group, and the proportions of households that are
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comprised by each specified age/sex group. This defines
the potential for improvement in rates, as evaluated by
the CRCI outcome measure.
Table 2 shows the distribution of households by
household type according to census definitions and the
distribution of the number of services for inclusion in
the CRCI outcome that the household members are
eligible for per household type. This is effectively a step
en route to calculation of the sample size requirements.
It is based on our determination of the detailed break-
down of household sizes and age/sex distributions
within them, found by modelling census data, including
on relative ages of married couples, and on ages of
mothers and fathers at birth of their children, plus other
census information as detailed in the methods section.
We considered all services, immunisations and screening
tests from Table 1, except chlamydia (since this is confi-
dential information and unlikely to be obtainable in
practice). Vaccine programmes such as rotavirus and
varicella that have not yet been introduced but those
that will be in the near future have been given estimated
uptake rates based on similar vaccine programmes.
Using the simulated household characteristics modelled
from the census, and the reported uptake rates for each
service (except chlamydia) and assuming no disease risk
factor clustering at the household level, then overall
11.7% of households are eligible for no services, 26.4%
for 1, 20.7% for 2, 15.3% for 3 and 25.8% for 4 or more.
The sample size needed to power a controlled inter-
vention study is shown in Table 3. The estimates depend
strongly on intervention percentage effect. We simulated
the sample size requirements for when 10%, 20% and
30% of services, immunisations or screening procedures
which otherwise would not have been taken up, are
taken up as a result of the CHW intervention. To dem-
onstrate a small CHW intervention percentage effect
(10%) and assuming low intra-household clustering for
disease risk factors and uptake of services, and low
intra-CHW ICC, 1,650 households would be needed in
each of the intervention and control arms - equating to
17 CHWs in the intervention arm. If the CHWs were
more effective (30%), then only 170 households would
Table 2 Service eligibility for services included in the Composite Referral Completion Indicator (CRCI) by household
type based on England and Wales population structurea
Household type Prevalence Proportion according to degree of service eligibility
No services One service Two services Three services ≥ Four services
Single person (16 to 64) 17.59% 43.3% 36.1% 14.2% 5.1% 1.3%
Single person (65 plus) 12.49% 0.0% 75.2% 21.4% 3.2% 0.3%
Marriedb (at least one < 65), no children 17.36% 13.4% 30.1% 26.4% 16.2% 13.9%
Marriedb (65 plus), no children 8.17% 0.0% 0.0% 24.7% 27.9% 47.3%
Marriedbc with one dependent child 8.34% 1.1% 13.3% 27.6% 26.3% 31.7%
Marriedbc with two or more dependent children 12.04% 0.4% 3.2% 9.1% 17.7% 69.7%
Marriedc with only non-dependent child(ren) 6.25% 3.9% 13.6% 20.9% 22.3% 39.3%
Lone mothers with one dependent child 3.44% 1.9% 20.2% 35.6% 21.8% 20.5%
Lone mothers with two or more dependent children 2.72% 0.0% 4.4% 14.5% 19.3% 61.7%
Lone mothers with only non-dependent child(ren) 2.10% 9.5% 24.5% 29.8% 19.0% 17.1%
Lone fathers with one dependent child 0.43% 7.0% 38.4% 27.9% 12.8% 14.0%
Lone fathers with two or more dependent children 0.35% 1.4% 5.8% 17.4% 27.5% 47.8%
Lone fathers with only non-dependent child(ren) 1.34% 23.2% 33.7% 27.0% 12.0% 4.1%
Same-sex partnerships, no children 0.26% 27.5% 19.6% 33.3% 7.8% 11.8%
Same-sex partnerships with child(ren) 0.01% 0.0% 0.0% 0.0% 50.0% 50.0%
Other households (including extended families)
with one dependent child
0.97% 0.0% 0.5% 8.2% 20.1% 71.1%
Other households (including extended families)
with > one dependent child
0.87% 0.0% 0.0% 0.6% 6.4% 93.1%
Student households, all students 0.55% 10.1% 22.9% 23.9% 20.2% 22.9%
Other households (all 65 plus) 0.29% 0.0% 0.0% 21.1% 36.8% 42.1%
Other households (not all 65 plus) 4.48% 15.4% 21.9% 24.4% 16.3% 22.0%
TOTAL/Weighted average proportions 100.00% 11.7%% 26.4%% 20.7% 15.3% 25.8%
aExcluding chlamydia services, assuming disease risk factors are not clustered at household level.
bMarried includes cohabiting couples of opposite sex. cSome ‘other households with dependent children’ are incorporated within these categories.
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Table 3 Sample sizes for a controlled intervention study with Composite Referral Completion Indicator (CRCI) as the outcome measure, based on England and
Wales population structurea
Level of similarity within households
in disease risk factors/level of similarly
within households in level of compliance
of uptake of interventions
Intervention
percentage
effect
Mean (SD)
CRCI in
control arm
Mean (SD)
CRCI in
CHW arm
Sample size number of households per arm based on comparison of mean CRCIs, allowing for
inclusion of householdsb without valid CRCI:
Without
clustering of
intervention by
region
With clustering of
intervention by regions
of 100 households,
Intra-CHW ICC = 0.01
With clustering of
intervention by regions
of 100 households,
Intra-CHW ICC = 0.02
With clustering of intervention
by regions of 100 households,
Intra-CHW ICC = 0.05
Typical distribution across England and
Wales: none/none
10% 0.56 (0.36) 0.61 (0.36) 1,650 3,280 4,920 9,820
none/none 20% 0.56 (0.36) 0.65 (0.35) 400 800 1,190 2,380
none/none 30% 0.56 (0.36) 0.69 (0.34) 170 340 510 1,010
none/high 10% 0.56 (0.41) 0.61 (0.39) 1,970 3,920 5,870 11,720
none/high 20% 0.56 (0.41) 0.65 (0.38) 490 980 1,460 2,920
none/high 30% 0.56 (0.41) 0.69 (0.36) 210 420 630 1,250
high/none 10% 0.6 (0.37) 0.64 (0.36) 1,990 3,960 5,930 11,840
high/none 20% 0.6 (0.37) 0.68 (0.35) 490 980 1,460 2,920
high/none 30% 0.6 (0.37) 0.72 (0.33) 210 420 630 1,250
high/high 10% 0.6 (0.41) 0.64 (0.39) 2,470 4,920 7,360 14,700
high/high 20% 0.6 (0.41) 0.68 (0.38) 590 1,170 1,760 3,510
high/high 30% 0.6 (0.41) 0.72 (0.36) 250 500 750 1,490
Typical distribution of deprived areas
none/none
10% 0.57 (0.36) 0.61 (0.35) 1,650 3,280 4,920 9,820
none/none 20% 0.57 (0.36) 0.66 (0.34) 400 800 1,190 2,380
none/none 30% 0.57 (0.36) 0.7 (0.33) 170 340 510 1,010
none/high 10% 0.57 (0.4) 0.62 (0.39) 1,970 3,920 5,870 11,720
none/high 20% 0.57 (0.4) 0.66 (0.37) 480 960 1,430 2,860
none/high 30% 0.57 (0.4) 0.7 (0.36) 210 420 630 1,250
high/none 10% 0.6 (0.36) 0.64 (0.35) 2,010 4,000 5,990 11,960
high/none 20% 0.6 (0.36) 0.68 (0.34) 480 960 1,430 2,860
high/none 30% 0.6 (0.36) 0.72 (0.33) 210 420 630 1,250
high/high 10% 0.6 (0.4) 0.64 (0.39) 2,400 4,780 7,150 14,280
high/high 20% 0.6 (0.4) 0.68 (0.37) 580 1,150 1,730 3,450
high/high 30% 0.6 (0.4) 0.72 (0.35) 250 500 750 1,490
a(Excluding chlamydia) and based on 90% power at 5% significance level. b88.3% of households have valid CRCI with no intra-household correlation of disease risk factors, and 84.8% of households have valid CRCI
based on high intra-household correlation of disease risk factors. Intervention percentage effect is proportion of services (immunisations/screening tests, stop-smoking clinics) that are taken up with CHW intervention,
out of those services that would not otherwise be taken up.
Abbreviations: CHW Community Health Worker, ICC intra-class correlation coefficient.
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be needed in each of the intervention and control arms
to demonstrate this, which equates to only 1 or 2 CHWs
in the intervention arm (though at least 5 to 10 would
be needed for generalisability of findings).
In deprived areas, there are far more single parent
households (15% with one or more dependent children)
than in England and Wales as a whole (8%). Other
households containing dependent children also make up
a slightly larger proportion of the total (that is the married/
cohabiting group and particularly other households with
dependent children). The number married/cohabiting
without children is reduced (14% in the deprived commu-
nity compared to 26% in England and Wales). Distribution
of household types for a typically deprived area results in
slightly higher proportions of households with measurable
outcomes (89.2% rather than 88.3% without correlation of
disease risk factors). This has a negligible effect on sample
sizes (within 3% of those in Table 3).
We modelled the distribution of service eligibility with
the extreme clustering of disease risk factors (smoking,
diabetes and at-risk flu vaccine) within households
(more extreme than would be found in practice). This
results in fewer households that are eligible for any ser-
vice (84.8%), and an increase in sample sizes require-
ments of 19 to 26%. Modelling strong clustering of
uptake of services within households also results in an
increase in sample sizes by around 19 to 24%. The intra-
CHW ICC has a much greater effect on the sample size
requirements. With an ICC of 0.01 and 100 households
per CHW, sample size requirements are doubled, com-
pared to if there was no intra-CHW clustering. They are
trebled for an ICC of 0.02, and 6-fold for ICC of 0.05.
For the greatest clustering throughout, with an intra-
CHW ICC of 0.05 and high intra-household clustering
(clustering of disease risk factors and uptake rates), then
between 10,000 and 14,000 households (that is 100 to
140 CHWs) would be needed in both control and inter-
vention arms to show a 10% intervention percentage
effect, and 1,000 to 1,400 households in each arm (and
10 to 14 CHWs in total) would be needed to show a
30% intervention percentage effect.
Discussion
We have modelled a composite process outcome score
for a complex CHW intervention applied to a hypo-
thesised population in North Wales. This modelling
exercise could be applied in other scenarios. The steps
we took were: (1) find distribution of eligibility to differ-
ent aspects of the composite outcome score (at house-
hold level in our example since the outcome is defined
at household level, but more typically at individual level),
and simulate a large population for this purpose, (2)
apply knowledge of the distribution of the different com-
ponents of the outcomes in the population in the
absence of any intervention, using random sampling
from the Bernoulli distribution for each individual com-
ponent of the outcome measures, (3) suggest plausible
effectiveness of the intervention, and (4) apply know-
ledge of the distribution of the different components of
the outcomes with the intervention, using random sam-
pling from the Bernoulli distribution for each individual
component of the outcome measure.
Using this approach we found that large sample sizes
would be needed to undertake an intervention study
basing the primary outcome on the CRCI, and yet these
sizes are potentially achievable. For an intervention per-
centage effect of just 10%, around 2,000 households may
be needed per arm. For an intervention percentage effect
of 20% and of 30%, only a quarter and a tenth of the
number of households is required.
It is noteworthy that the time when such an interven-
tion study period is started should correspond to a time
before the start of the flu season, and end after the end
of the season, so that its effect on this vaccination can
best be calculated. It would be appropriate to take an
intervention period of at least a year (the time period
used in this simulation). A period of 3 years may be
preferable, since some cancer screening tests are sched-
uled every 3 years, but then it may not be desirable to
wait too long before evaluating the result. The apparent
effect of any such intervention may be different in the
first year of its operation (when there may be more pre-
viously untapped demand to pick up), compared to
when it has been running for some time.
Other CHW projects of a similar nature have elected
to use single primary outcomes as a measure of the
CHW impact, with other measures relegated to second-
ary importance [41]. However, the CHW project we have
proposed is not an intervention for the improvement of,
as examples, HbA1c or blood pressure measurements,
alone. Rather it is an intervention to improve, broadly,
the interface between the household and primary care -
ensuring that individuals with expressed and un-
expressed need or demand are appropriately referred to
the correct service in a timely manner. For this, process
measures such as service utilisation are needed, and the
CRCI tells us whether the home-based CHW interven-
tion improves overall service uptake and utilisation. This
is reasonable because the intervention is likely to elicit
an effect across all components of the composite score
and there is causal relevance between the intervention
and each component of the CRCI [42]. Uptake of a ser-
vice may not only be the result of the CHWs’ efforts,
and so the CRCI does need to be interpreted against a
control group. The components of a composite out-
come score should always be declared as secondary
outcomes and described alongside the primary compos-
ite score [9].
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In pharmaceutical trials, the components of a compos-
ite score are measurable events that can sensibly be
added together as being aspects of the same underlying
disease process. Although the CRCI does not measure a
disease process but instead a CHW intervention, the
principles are the same. The CRCI is likely to have a
high reliability, because its elements are derived from
routinely collected source data. Vaccination records and
stopping-smoking clinic referrals are, for example, ex-
tracted from GP records and screening attendance is
extracted from screening clinic records. Its validity
depends on the remit of the CHW - in our case, the
focus is on improving uptake of screening, vaccination
and smoking cessation clinics; however, there are several
other areas that are also worthy of evaluation, for ex-
ample, impact on self-efficacy, health knowledge, com-
munity cohesion and so on. In practice, other outcomes
should be used alongside this summary CRCI measure
and the cost, feasibility and sensitivity to measure effects
of the CRCI will all need to be examined.
CHW interventions that aim to increase uptake of ser-
vices for which families are eligible are quite likely to in-
crease costs; however, it is likely that this will be off-set
in the long term by the gains from early disease detec-
tion and avoidance of hospitalisation. Uptake of breast-
feeding, stopping someone smoking, and early diagnosis
of breast cancer will each yield different long-term gains.
At a simplistic level, health economists could calculate
the cost per relevant unit of increase in the CRCI (for
example, a percentage increase in uptake for services for
which families are eligible). However, this would not rec-
ognise fully the complex nature of the relationship be-
tween uptake of services and the potential health gains
from each service. The CRCI approach poses challenges
for health economists who have traditionally focused on
single outcome measures in cost-effectiveness analysis.
How a composite measure might be linked to interven-
tion costs needs to be considered.
Modelling the CRCI against a variety of possible sce-
narios of population, household and clustering charac-
teristics, we have been able to use it to calculate sample
sizes for a future cluster RCT (or other comparison
study) for this kind of intervention. This adds value to
the evaluation of complex interventions for a number of
reasons. Firstly, use of the CRCI as a primary outcome is
likely to result in increased statistical power over consid-
eration of any one individual screening/immunisation
programme alone. Another merit is that it supports the
overall purpose of the intervention, that is to have a wide
focus in their activities, because the CRCI does not single
out any one service above others in their importance. Nar-
rowly defined primary outcome measures distort complex
interventions in RCT contexts. The CRCI may be some-
what harder to interpret, since different elements are
incorporated within it; however, to mitigate this, uptake
rates for the individual components parts of it can be re-
ported alongside the total CRCI, to show which individual
changes make up any CRCI changes. They could be re-
ported with confidence intervals, but without individual
testing for significance, since these tests would generally
be underpowered.
In our simulation exercise, we found that 85 to 89% of
all households will have at least one person who is
eligible for a service and, therefore, could be included in
the CRCI calculation. Subject to the data being able to
be collected from routine sources (possible in all but
chlamydia screening which we have therefore excluded
from our definition of CRCI) the CRCI can be calculated
in a meaningful way and, because it is a comparison of
proportions, poses little statistical complexity in terms of
its analysis. The CRCI is dependent on the availability
and completeness of secondary data - but this is becom-
ing increasingly more accessible though linked datasets
such as SAIL or CPRD [43]. In this example, screening
records and vaccination records can be matched to indi-
vidual household members, for use in evaluation with all
data, whether in the intervention or control groups, de-
rived from routinely collected sources. If a similar evalu-
ation were proposed in a country where it is not
possible to do such matching, this CRCI tool could still
potentially be used on a large regional basis, with CHWs
introduced into some regions and not others. For this
purpose, CRCI would need to be measured at regional
level rather than at household level.
Even allowing for clustering at the household level,
the CRCI could be a suitable primary outcome score -
sample sizes required to demonstrate even small changes
in the CRCI between the control and intervention
groups are within practical limits, that is around 60
CHWs would be needed to show a 10% increase in the
CRCI even if households and clusters are correlated to a
plausible degree (with an intra-CHW ICC of 0.02). Brazil
has pursued a national policy to scale and integrate
CHWs into all primary care teams and now employs
over 250,000 CHWs throughout the country. It has seen
a corresponding decrease in hospitalisations for primary
care conditions, infant mortality, and horizontal inequity
[15-20]. In our cluster RCT, we would only need to re-
cruit around a dozen large general practices for an
adequately powered study.
Individuals, rather than households, are generally con-
sidered to be units of analysis in clinical and health ser-
vices research. However, considering the likely clustering
of disease risk factors and health-seeking behaviours, and
also the type of intervention that we are proposing, in
complex interventions such as this it may be advantageous
to consider the household as a unit of analysis. Our calcu-
lations show that around 40% of households of England
Watt et al. Trials  (2015) 16:107 Page 9 of 11
and Wales will contain members that are eligible for 3 or
more services. We also found that the proportion of the
simulated population that has taken up a service that it is
eligible for is as low as 56 to 60%. This suggests that
current strategies to signpost towards available services
are inadequate, but equally that intervening at the house-
hold level, as opposed to targeting individuals, may be an
efficient approach to improving uptake.
Although the CRCI covers over a dozen different nationally
available services, there may be other benefits to the CHW
service not captured by the CRCI such as mental health
improvements or reductions in GP consultations or hospital
referrals. Nonetheless, we think the CRCI is a useful first step
towards a process-centred composite score of practical value
in complex community-based interventions. It may be useful
in the UK and in other countries, where its composition
would depend on which screening strategies and immunisa-
tion services are provided in the relevant country.
Conclusion
The modelling described indicates that a composite process
outcome indicator may have some validity in the context of
a complex intervention. The indicator is straightforward in
terms of data collection and analysis and could potentially
be utilised to measure other complex interventions or be
adapted to include specific services depending on the
context. Composite outcome scores are useful to increase
the power of the statistical analysis around an intervention.
For interventions that are not amenable to traditional com-
posites, such as all-cause mortality, the CRCI described
here, might be a useful alternative by measuring processes,
such as service utilisation, rather than clinical outcomes.
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